Tagworks Pharmaceuticals Email Format

Pharmaceutical Manufacturinggelderland, Netherlands11-50 Employees

Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted radionuclide therapies. 
We are headquartered in the Netherlands with operations in the U.S. For more information, visit us at www.tagworkspharma.com.

✕

Access Insights for Tagworks Pharmaceuticals and Millions of Other Companies

Sign up for full access to Tagworks Pharmaceuticals information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory